MicroPort

$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 20, 2023
Health, Medical Devices, Cardiology, Heart failure, Prevalence, Boston Scientific, Abbott Laboratories, ECMO, CAD, SHD, Incidence, Medtronic, Edwards Lifesciences, MicroPort, Investment, Developed country, Medical tourism, Geography, Medical device, Pharmaceutical industry

The "Heart Failure Devices Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Heart Failure Devices Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.
  • The heart failure devices global market expected to grow at high single-digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029.
  • Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure devices, rising geriatric population, and favorable reimbursement are the drivers, vast pipeline products, increase in funding and approvals are the opportunities.
  • The heart failure devices market based on products is segmented as cardiac rhythm products, cardiac assist devices (CAD), structural heart devices (SHD), ECMO and others (modulation devices).

Orthopedic Devices Market worth $48.1 billion | MarketsandMarkets

Retrieved on: 
Thursday, March 16, 2023
Stryker Corporation, Research, ITS, MicroPort, Quality of life, Johnson & Johnson, Posture, Roe, Accident, Smith & Nephew, DeRoyal, Hospital, NuVasive, Risk, Bleeding, Tetraplegia, Bone, Patient, Government, Ageing, Pain, Medtronic, Growth, Incidence, Sport, Safety, Toys "R" Us Canada, II, Pharmaceutical industry, Dentistry, Medical device, 3D printing, Nursing, Enovis

The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028.

Key Points: 
  • The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028.
  • In September 2022, Stryker Corporation introduced New Gamma4 Hip fracture nailing system to expand its orthopedic fixation devices product portfolio.
  • Orthopedic devices help to alleviate pain and improve the quality of life for patients suffering from various orthopedic conditions.
  • Orthopedic devices are minimally invasive, making them easy to use and less risky than traditional treatments.

Orthopedic Devices Market worth $48.1 billion | MarketsandMarkets

Retrieved on: 
Thursday, March 16, 2023
Stryker Corporation, Research, ITS, MicroPort, Quality of life, Johnson & Johnson, Posture, Roe, Accident, Smith & Nephew, DeRoyal, Hospital, NuVasive, Risk, Bleeding, Tetraplegia, Bone, Patient, Government, Ageing, Pain, Medtronic, Growth, Incidence, Sport, Safety, Toys "R" Us Canada, II, Pharmaceutical industry, Dentistry, Medical device, 3D printing, Nursing, Enovis

The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028.

Key Points: 
  • The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028.
  • In September 2022, Stryker Corporation introduced New Gamma4 Hip fracture nailing system to expand its orthopedic fixation devices product portfolio.
  • Orthopedic devices help to alleviate pain and improve the quality of life for patients suffering from various orthopedic conditions.
  • Orthopedic devices are minimally invasive, making them easy to use and less risky than traditional treatments.

Haizol Launch 3D Printing Service to Expand their Manufacturing Capabilities to Customers Worldwide

Retrieved on: 
Tuesday, March 14, 2023
FDM, Toy, Control, Equipment, SLA, USB On-The-Go, Stamp, Prototype, Fabrication, Roche, Head, Plastic, SLS, MicroPort, Injection moulding, Metal, Design engineer, Machine, 3D, MJF, CAD, 3D printing, Molding, Zeiss, Electronics, Haier

LONDON, March 13, 2023 /PRNewswire-PRWeb/ -- To meet increasing demand, Haizol now offer 3D printing on-demand to customers all across the globe, adding to the one-stop shops capabilities from CNC Machining and Injection Molding, to Casting and Stamping. This addition will allow small to medium sized businesses access to top of the range 3D printing technology to produce their parts or products, at a fraction of the cost to manufacture in-house. Through Haizol's extensive network, business of all sizes can benefit from 3D printing capabilities in whichever capacity is needed for them.

Key Points: 
  • Leading digital manufacturer Haizol has announced an expansion of production capabilities within its global manufacturing service.
  • Through Haizol's extensive network, business of all sizes can benefit from 3D printing capabilities in whichever capacity is needed for them.
  • Partnering with the best manufacturers in China for additive manufacturing, they deliver custom prototypes and end-use production parts for buyers worldwide.
  • Haizol's 3D printing services access the best 3D printing machines in the industry.

Global Minimally Invasive Surgical (MIS) Devices Market to Reach $42.4 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 4, 2023
Surgery, Health, Medical Devices, Lung cancer, Abbott, Stomach, Competitive landscape, MicroPort, International Agency for Research on Cancer, The Cooper Companies, Food, MIS, COVID-19, Organic, RAS, USD, Top 40, Prostate, Olympus, CE, Research, Growth, Medtronic, KARL, Intuitive Surgical, Alpha Group Co., Ltd., US Foods, Boston Scientific, Minimally invasive procedure, Degenerative disease, BD, Hugot, Ageing, Liver, Incidence, CE marking, Prevalence, Neurodegeneration, Medical device, Dietary supplement, Medical imaging, Flowers, Cancer

The "Minimally Invasive Surgical (MIS) Devices - Market Insight, Competitive Landscape and Market Forecast - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Minimally Invasive Surgical (MIS) Devices - Market Insight, Competitive Landscape and Market Forecast - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global MIS devices market was valued at USD 28,873.25 million in 2021, growing at a CAGR of 7.38% during the forecast period from 2022 to 2027, in order to reach USD 42,499 million by 2027.
  • Minimally Invasive Surgical (MIS) Devices Market Dynamics:
    One of the key aspects driving the MIS devices market can be attributed to the surge in cancer incidence.
  • Various end-users who want to know more about the MIS devices market and latest technological developments in the MIS devices market.

MicroPort MedBot NaviBot Announces First Clinical Use of Skywalker™ Surgical Robot for Total Knee Procedures

Retrieved on: 
Thursday, December 1, 2022
Endoscopy, MicroPort, Elective surgery, Multimedia, China Hi-Tech Group Co., Ltd., Commercial Operating System (COS), Instability, Patient, APG system, Workflow, Patient satisfaction, Robotics, Surgeon, Motion, Knee, FDA, Medical device, Dentistry

MicroPort MedBot also intends to integrate new applications on its platform including Hip replacement as a next application in early 2024.

Key Points: 
  • MicroPort MedBot also intends to integrate new applications on its platform including Hip replacement as a next application in early 2024.
  • The SkyWalker Surgical Robotic System for the total knee is its 1st approved application, provides surgeons enhanced capability of customized preoperative planning and accurate intraoperative robotic assistance during total knee arthroplasty.
  • MicroPort NaviBot International LLC is a subsidiary of NaviBot (Suzhou) Co., Ltd. (hereinafter referred to as " NaviBot Suzhou").
  • The SkyWalker surgical robot is an FDA cleared system of MicroPort NaviBot International LLC.

Stereotaxis Reports 2022 Third Quarter Financial Results

Retrieved on: 
Thursday, November 10, 2022
Ecosystem, GLOBE, Operating cost, Marginal cost, Forward-looking statement, NYSE, U.S. Securities and Exchange Commission, Intelligence, Pandemic, Electrophysiology, Health, MicroPort, Genesis, Technology, Safety, International, Magic, Contract, CE marking, Company, Physician, Patient, CEO, Security (finance), Disaster, Medical device, Video game, Stereotaxis

ST. LOUIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2022.

Key Points: 
  • ST. LOUIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2022.
  • Revenue for the third quarter of 2022 totaled $7.7 million, compared to $9.1 million in the prior year third quarter.
  • At September 30, 2022, Stereotaxis had cash and cash equivalents, including restricted cash, of $32.4 million and no debt.
  • Stereotaxis will host a conference call and webcast today, November 10, 2022, at 10:00 a.m. Eastern Time.

MicroPort Orthopedics and Pixee Medical Announce the Commercialization of its Orthopedic Surgery Technology in the U.S.

Retrieved on: 
Thursday, November 3, 2022
MicroPort, Arthroplasty, Elective surgery, Solution, Advance, FDA, Smartglasses, Surgeon, CEO, Technology, Efficiency, Patient, Quality of life, Hip, Motion, Partnership, Knee, Multimedia, Learning, ASC, Medical device, Dentistry, Hospital

ARLINGTON, Tenn., Nov. 3, 2022 /PRNewswire/ -- MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces the expansion of its partnership with Pixee Medical through the commercialization of its combined surgical solution in the United States. Utilizing Pixee Medical's FDA-cleared augmented reality surgical application for assistance in total knee arthroplasty, the surgeon can achieve precision and control when implanting MicroPort Evolution® Medial-Pivot Knee Implant. This solution is currently being used in thousands of successful cases around the world including in Australia, Europe, and Asia. 

Key Points: 
  • The MicroPort Orthopedics Evolution Medial-Pivot Knee Implant delivers a high degree of stability and motion, leading to increased patient satisfaction1 and survivorship1.
  • Combining MicroPort's innovative devices with Pixee Medical's platform is allowing patients, worldwide, access to surgery solutions integrating top of the class technologies.
  • Pixee Medical's ambition is to empower all orthopedic surgeons with the latest breakthrough in precision surgery, to become digitally augmented surgeons.
  • Pixee Medical's augmented surgery platform is commercially available in Europe, Australia, and the USA for total knee arthroplasty with Knee+.

MicroPort Orthopedics Releases the HIPTURN™ Tensioning Instrument: An Exclusive in-situ Trialing Device

Retrieved on: 
Wednesday, November 2, 2022
Surgeon, MicroPort, Dynasty, Orthopedic surgery, View, Safety, Trauma, Patient, Multimedia, Reduction, Solution, Dentistry, Medical device

ARLINGTON, Tenn., Nov. 2, 2022 /PRNewswire/ -- MicroPort Orthopedics is a medical device company specializing in large joint replacements with clinical data/history dating back over 20 years.

Key Points: 
  • ARLINGTON, Tenn., Nov. 2, 2022 /PRNewswire/ -- MicroPort Orthopedics is a medical device company specializing in large joint replacements with clinical data/history dating back over 20 years.
  • The HIPTURN tensioning instrument was recently shown at a global Hip and Knee meeting where it was met with intrigue and excitement.
  • MicroPort believes not only will the HIPTURN be successful as a product, but more importantly, it will bring higher quality of care to patients.
  • The HIPTURN tensioning instrument saves time, causes less tissue trauma and could revolutionize the way total hip arthroplasty is performed."

MicroPort Orthopedics Expands Commercial Leadership Team with Global Vice President of Marketing and Professional Education and North America Vice President of Sales

Retrieved on: 
Thursday, October 6, 2022
Shawn, Marketing, Hillrom, National accounts, Johnson & Johnson, MicroPort, Global, Patient, Medtronic, Multimedia, Partnership, Goal, Industry, Leadership, Zimmer Biomet, Elective surgery, Hip, Medical education, Smith & Nephew, Surgeon, View, Stryker, Management, Medicine, Gustav Tornier

ARLINGTON, Tenn., Oct. 6, 2022 /PRNewswire/ -- MicroPort Orthopedics, a global leader in orthopedic devices and technologies, announces today the expansion of its commercial leadership team with two strategic hires: Brian Collins is joining as Global Vice President of Marketing and Professional Education and Shawn Gabriel as Vice President of Sales, North America. Both Brian and Shawn have extensive experience in sales and marketing for medical devices.

Key Points: 
  • ARLINGTON, Tenn., Oct. 6, 2022 /PRNewswire/ -- MicroPort Orthopedics , a global leader in orthopedic devices and technologies, announces today the expansion of its commercial leadership team with two strategic hires: Brian Collins is joining as Global Vice President of Marketing and Professional Education and Shawn Gabriel as Vice President of Sales, North America.
  • Brian brings more than 12 years of experience in the medical device industry leading strategy and execution to the MicroPort Orthopedics team.
  • In his most recent role as Global Vice President of Marketing and Medical Education for ZimVie, he guided the successful spin-off from Zimmer Biomet.
  • As MicroPort Orthopedics VP of Sales for North America, Shawn will bring his experience and leadership to align and exceed sales goals.